View in EDS HTML Full Text PDF Full Text

The prevalence of sarcopenia in Parkinson's disease and related disorders- a systematic review.

Saved in:
Bibliographic Details
Title: The prevalence of sarcopenia in Parkinson's disease and related disorders- a systematic review.
Authors: Hart, Ashley (AUTHOR), Cordova-Rivera, Laura (AUTHOR), Barker, Fred (AUTHOR), Sayer, Avan A. (AUTHOR), Granic, Antoneta (AUTHOR), Yarnall, Alison J. (AUTHOR)
Source: Neurological Sciences. Dec2023, Vol. 44 Issue 12, p4205-4217. 13p.
Subjects: Parkinson's disease, Sarcopenia, Parkinsonian disorders, Movement disorders, Muscle mass, Muscle strength
Abstract: Background: The prevalence of sarcopenia (reduced skeletal muscle strength and mass), Parkinson's disease (PD) and Parkinson's related disorders (PRD) all increase with age. They also share risk factors and pathogenetic features. An increased prevalence of sarcopenia in PD and PRD than the general population was thus postulated. Methods: Four databases were searched using predefined literature search strategies. Studies conducted in participants with PD or PRD reporting the prevalence of sarcopenia and those providing data to compute the prevalence were included. Pre-sarcopenia, probable/possible sarcopenia and confirmed sarcopenia were defined according to the main sarcopenia working groups. Risk of bias was assessed using the AXIS tool. Results: 1978 studies were identified; 97 assessed in full; 14 met inclusion criteria. The median study quality score was 15/20. The range of probable sarcopenia was 23.9 to 66.7%, and it did not change after excluding PRD participants. The prevalence of confirmed sarcopenia in participants with any parkinsonian disorder ranged from 2 to 31.4%. Including just PD participants, the range was 10.9 to 31.4%. In studies with controls, sarcopenia was more prevalent in PD and PRD. There was a positive non-significant trend between severity of motor symptoms and prevalence of sarcopenia or components of sarcopenia. High heterogeneity precluded meta-analysis, therefore there was insufficient evidence to conclude whether sarcopenia is more prevalent in PD or PRD. Conclusions: Probable and confirmed sarcopenia are common in PD and PRD and they may be associated with disease severity. This co-occurrence supports the value of screening for sarcopenia in parkinsonian populations. [ABSTRACT FROM AUTHOR]
Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 173558410
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The prevalence of sarcopenia in Parkinson's disease and related disorders- a systematic review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Hart%2C+Ashley%22">Hart, Ashley</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cordova-Rivera%2C+Laura%22">Cordova-Rivera, Laura</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Barker%2C+Fred%22">Barker, Fred</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sayer%2C+Avan+A%2E%22">Sayer, Avan A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Granic%2C+Antoneta%22">Granic, Antoneta</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yarnall%2C+Alison+J%2E%22">Yarnall, Alison J.</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. Dec2023, Vol. 44 Issue 12, p4205-4217. 13p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Parkinson's+disease%22">Parkinson's disease</searchLink><br /><searchLink fieldCode="DE" term="%22Sarcopenia%22">Sarcopenia</searchLink><br /><searchLink fieldCode="DE" term="%22Parkinsonian+disorders%22">Parkinsonian disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Movement+disorders%22">Movement disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Muscle+mass%22">Muscle mass</searchLink><br /><searchLink fieldCode="DE" term="%22Muscle+strength%22">Muscle strength</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: The prevalence of sarcopenia (reduced skeletal muscle strength and mass), Parkinson's disease (PD) and Parkinson's related disorders (PRD) all increase with age. They also share risk factors and pathogenetic features. An increased prevalence of sarcopenia in PD and PRD than the general population was thus postulated. Methods: Four databases were searched using predefined literature search strategies. Studies conducted in participants with PD or PRD reporting the prevalence of sarcopenia and those providing data to compute the prevalence were included. Pre-sarcopenia, probable/possible sarcopenia and confirmed sarcopenia were defined according to the main sarcopenia working groups. Risk of bias was assessed using the AXIS tool. Results: 1978 studies were identified; 97 assessed in full; 14 met inclusion criteria. The median study quality score was 15/20. The range of probable sarcopenia was 23.9 to 66.7%, and it did not change after excluding PRD participants. The prevalence of confirmed sarcopenia in participants with any parkinsonian disorder ranged from 2 to 31.4%. Including just PD participants, the range was 10.9 to 31.4%. In studies with controls, sarcopenia was more prevalent in PD and PRD. There was a positive non-significant trend between severity of motor symptoms and prevalence of sarcopenia or components of sarcopenia. High heterogeneity precluded meta-analysis, therefore there was insufficient evidence to conclude whether sarcopenia is more prevalent in PD or PRD. Conclusions: Probable and confirmed sarcopenia are common in PD and PRD and they may be associated with disease severity. This co-occurrence supports the value of screening for sarcopenia in parkinsonian populations. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=173558410
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10072-023-07007-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 4205
    Subjects:
      – SubjectFull: Parkinson's disease
        Type: general
      – SubjectFull: Sarcopenia
        Type: general
      – SubjectFull: Parkinsonian disorders
        Type: general
      – SubjectFull: Movement disorders
        Type: general
      – SubjectFull: Muscle mass
        Type: general
      – SubjectFull: Muscle strength
        Type: general
    Titles:
      – TitleFull: The prevalence of sarcopenia in Parkinson's disease and related disorders- a systematic review.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hart, Ashley
      – PersonEntity:
          Name:
            NameFull: Cordova-Rivera, Laura
      – PersonEntity:
          Name:
            NameFull: Barker, Fred
      – PersonEntity:
          Name:
            NameFull: Sayer, Avan A.
      – PersonEntity:
          Name:
            NameFull: Granic, Antoneta
      – PersonEntity:
          Name:
            NameFull: Yarnall, Alison J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 15901874
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Neurological Sciences
              Type: main
ResultId 1